UW Medicine administers new Alzheimer's drug for the first time

By The Seattle Times
| December 04, 2023

The IV drug, created by Japanese drugmaker Eisai, is covered by Medicare and deemed safe and effective for patients with mild dementia and other symptoms caused by early Alzheimer's.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...